TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Elexir Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
72,228
|
58,190
|
59,011 |
Financial expenses |
7
|
35
|
9 |
Earnings before taxes |
8,226
|
8,015
|
8,982 |
EBITDA |
8,315
|
8,136
|
9,225 |
Total assets |
30,475
|
23,379
|
22,141 |
Current assets |
28,103
|
22,894
|
21,632 |
Current liabilities |
8,806
|
6,422
|
5,876 |
Equity capital |
20,735
|
16,279
|
14,476 |
- share capital |
34
|
33
|
36 |
Employees (average) |
15
|
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.0%
|
69.6%
|
65.4% |
Turnover per employee |
4,815
|
5,819
|
5,901 |
Profit as a percentage of turnover |
11.4%
|
13.8%
|
15.2% |
Return on assets (ROA) |
27.0%
|
34.4%
|
40.6% |
Current ratio |
319.1%
|
356.5%
|
368.1% |
Return on equity (ROE) |
39.7%
|
49.2%
|
62.0% |
Change turnover |
13,738
|
3,959
|
10,003 |
Change turnover % |
23%
|
7%
|
20% |
Chg. No. of employees |
5
|
0
|
3 |
Chg. No. of employees % |
50%
|
0%
|
43% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.